Jian Liu

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Oxide Nanoparticles

Structure Activity Relationship

Molecular Docking

Estrogen Receptor

Top Venues

Journal of medicinal chemistry

The Journal of organic chemistry

Organic letters

Journal of chemical information and modeling

This page only lists publications with an associated author ORCID identifier.

Publications

Jiacong Li, Yong Nian, Jian Liu, Mingxia Yang, Yuanling Jin, Xiaoman Kang, Haodong Xu, Zhuo Shang, Wei Lin
Identification of a Potential Antimycobacterial Drug Sensitizer Targeting a Flavin-Independent Methylenetetrahydrofolate Reductase. ACS omega 8 (41) (2023)
Ping Wang, Hongqiong Yang, Weijiang Lin, Jingxian Zhou, Yi Liu, Lingyu Ma, Mengting Li, Yang Hu, Chengli Yu, Yi-Nan Zhang, Qi Lv, Jian Liu, Lihong Hu
Discovery of Novel Sesquiterpene Lactone Derivatives as Potent PKM2 Activators for the Treatment of Ulcerative Colitis. Journal of medicinal chemistry (2023)
Rupeng Dai, Xueting Bao, Ying Zhang, Yan Huang, Haohao Zhu, Kundi Yang, Bo Wang, Hongmei Wen, Wei Li, Jian Liu
Hot-Spot Residue-Based Virtual Screening of Novel Selective Estrogen-Receptor Degraders for Breast Cancer Treatment. Journal of chemical information and modeling (2023)
Yueyue Zhu, Rupeng Dai, Chaoqun Huang, Wang Zhou, Xiaoyuan Zhang, Kundi Yang, Hongmei Wen, Wei Li, Jian Liu
Synthesis of Isoquinolone, 1,2-Benzothiazine, and Naphtho[1',2':4,5]imidazo[1,2- a ]pyridine Derivatives via Rhodium(III)-Catalyzed (4 + 2) Annulation. The Journal of organic chemistry 87 (17) (2022)
Xiaomeng Zhang, Yazhou Wang, Jianfeng Ji, Dongjuan Si, Xueting Bao, Zhuangzhuang Yu, Yueyue Zhu, Liwen Zhao, Wei Li, Jian Liu
Discovery of 1,6-Naphthyridin-2(1 H )-one Derivatives as Novel, Potent, and Selective FGFR4 Inhibitors for the Treatment of Hepatocellular Carcinoma. Journal of medicinal chemistry 65 (11) (2022)
Xiaomeng Zhang, Yazhou Wang, Xue Li, Jie Wu, Liwen Zhao, Wei Li, Jian Liu
Dynamics-Based Discovery of Novel, Potent Benzoic Acid Derivatives as Orally Bioavailable Selective Estrogen Receptor Degraders for ERα+ Breast Cancer. Journal of medicinal chemistry 64 (11) (2021)
Junwei Wang, Xiang Pan, Yi Song, Jian Liu, Fei Ma, Ping Wang, Yan Liu, Lin Zhao, Di Kang, Lihong Hu
Discovery of a Potent and Selective FLT3 Inhibitor (Z)-N-(5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-4-methyl-1H-pyrrol-3-yl)-3-(pyrrolidin-1-yl)propanamide with Improved Drug-like Properties and Superior Efficacy in FLT3-ITD-Positive Acute Myeloid Leukemia. Journal of medicinal chemistry 64 (8) (2021)
Ning Ding, Junyang Wang, Jian Liu, Youjuan Zhu, Shurong Hou, Huimin Zhao, Yisheng Yang, Xiabin Chen, Lihong Hu, Xia-Chang Wang
Cytotoxic Guaianolide Sesquiterpenoids from Ainsliaea fragrans. Journal of natural products 84 (9) (2021)
Xiyan Rui, Chao Wang, Dongjuan Si, Xuechao Hui, Keting Li, Hongmei Wen, Wei Li, Jian Liu
One-Pot Tandem Access to Phenothiazine Derivatives from Acetanilide and 2-Bromothiophenol via Rhodium-Catalyzed C-H Thiolation and Copper-Catalyzed C-N Amination. The Journal of organic chemistry 86 (9) (2021)
Jian Liu, Yi Gao, Yehua Zhu, Junru Zhu, Chao Wang, Xiyan Rui, Kundi Yang, Dongjuan Si, Jiamin Lin, Dandan Yuan, Hongmei Wen, Wei Li
Rhodium(III)-Catalyzed Oxidative Annulation of 4-Aminoquinolines and Acrylate through Two Consecutive C(sp2)-H Activations. Organic letters 22 (7) (2020)
Junwei Wang, Xiang Pan, Lei Zhao, Lin Zhao, Jian Liu, Ying Zhi, Ai Wang, Kun Zhao, Lihong Hu
Diastereoselective construction of 3-aryl-substituted indolines via annulation of in situ generated p-quinone methides. Organic & biomolecular chemistry 17 (48) (2019)